Thomas Pfisterer - Jun 13, 2024 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Role
Director
Signature
Lisa Kallebo, as Attorney-in-Fact for Thomas Pfisterer
Stock symbol
ADCT
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
4
Date filed
6/14/2024, 05:37 PM
Previous filing
Jan 2, 2024
Next filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADCT Common Shares Award $0 +40K +22.81% $0.00 215K Jun 13, 2024 Direct F1
holding ADCT Common Shares 452K Jun 13, 2024 By HPWH TH AG F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The reporting person disclaims beneficial ownership of all Common Shares held of record by HPWH TH AG ("HPWH"), other than the Common Shares in HPWH that are indirectly represented by the reporting person's 41.7% interest in HPWH MH AG, which owns a 12.5% interest in HPWH, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the remaining Common Shares in HPWH for purposes of Section 16 or for any other purpose.